SmPC - Ritonavir 100 mg Film-coated Tablets: Change history
View Summary of Product Characteristics (SmPC - Ritonavir 100 mg Film-coated Tablets)
Last updated on this site: 25 Mar 2024
Description of update: To update SmPC section 4.4 in line with information of reference product (Norvir 100 mg film-coated tablets, EU procedure number: EMEA/H/C/000127; MAH: AbbVie Deutschland GmbH & Co. KG, Germany) for Ritonavir Accord 100 mg film-coated tablets.
SmPC Sections updated: 4.4 and 10.
Last updated on this site: 25 Mar 2024
Description of update: To update SmPC section 4.4 in line with information of reference product (Norvir 100 mg film-coated tablets, EU procedure number: EMEA/H/C/000127; MAH: AbbVie Deutschland GmbH & Co. KG, Germany) for Ritonavir Accord 100 mg film-coated tablets.
SmPC Sections updated: 4.4 and 10.
-
Changes: (Updated: 25 Mar 2024)
Description of update: To update SmPC section 4.4 in line with information of reference product (Norvir 100 mg film-coated tablets, EU procedure number: EMEA/H/C/000127; MAH: AbbVie Deutschland GmbH & Co. KG, Germany) for Ritonavir Accord 100 mg film-coated tablets.
SmPC Sections updated: 4.4 and 10.
-
Changes: (Updated: 25 Mar 2024)
Description of update: To update SmPC section 4.4 in line with information of reference product (Norvir 100 mg film-coated tablets, EU procedure number: EMEA/H/C/000127; MAH: AbbVie Deutschland GmbH & Co. KG, Germany) for Ritonavir Accord 100 mg film-coated tablets.
SmPC Sections updated: 4.4 and 10.
-
Changes: (Updated: 28 Apr 2023)
Description of update: Type IB: C.I.2.a: To update SmPC and PIL in-line with the product Information of reference product (Norvir 100 mg film-coated tablets, EU procedure number: EU/1/96/016 MAH: AbbVie Deutschland GmbH & Co. KG , Germany) for Ritonavir Accord 100 mg film-coated tablets.
SmPC sections updated: 4.2, 4.5, 4.6, 4.8, 5.1, 5.2, 10.
-
Changes: (Updated: 21 Sep 2022)
Initial upload